Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Ayfer BecerenDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0002-6770-6089
Ayse Nur Hazar-YavuzDepartment of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.
Ozlem Bingol OzakpinarDepartment of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.
Duygu TaskinMarmara Pharmacy Drug and Innovative Product Development Unit, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.
Ismail SenkardesDepartment of Pharmaceutical Botany, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0002-2656-0319
Turgut TaskinMarmara Pharmacy Drug and Innovative Product Development Unit, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0001-8475-6478
Ozlem Tugçe Cilingir-KayaDepartment of Histology and Embryology, School of Medicine, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0002-2591-9174
Ahmad KadoISLAB-2 Core Laboratory, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul 34722, Türkiye.ORCID 0000-0002-8681-8502
Elif Caliskan SalihiMarmara Pharmacy Drug and Innovative Product Development Unit, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.ORCID 0000-0001-7852-3782
Hatice Kubra ElciogluDepartment of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Evaluation of the Cytotoxicity, Genotoxicity and Acute Oral Toxicity of · full record | OpenQuestion